The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksR8 Capital Inv Regulatory News (MODE)

  • This share is currently suspended. It was suspended at a price of 2.25

Share Price Information for R8 Capital Inv (MODE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.25
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.25
MODE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Mode partners with UK charity to enable donations

29 Jul 2021 07:00

RNS Number : 8284G
Mode Global Holdings PLC
29 July 2021
 

 

Mode Global Holdings PLC

("Mode" or "the Company" or "the Group")

 

Mode partners with UK charity to enable donations

 

● Customers to be able to donate to Young Lives vs Cancer via the Mode App

● Mode's 0.5% processing fee over 5x times cheaper than alternative donation options

● Charity to boost appeal to younger demographics through instant QR code-based donation solution

 

Mode Global Holdings PLC ("LSE:MODE"), the LSE-listed Fintech Group, announces that it has partnered with Young Lives vs Cancer to facilitate cheaper and faster donations through the Mode App.

 

Developed as an alternative to card payments, Mode's solution aims to counter rising transaction processing fees, which have exceeded 2.9%1 per donation in the charity sector, enabling charities to keep more of their hard earned donations. Mode's QR-code payments solution also provides an innovative, alternative way to donate instantly by using a smartphone, which boosts its appeal to younger, digitally-native demographics.

 

Mode's payment processing fee will be capped at 0.5% however, Young Lives vs Cancer will pay 0% fees for the first 6 months of the partnership, as part of Mode's pledge to donate the fee back to the charity.

 

The solution enables secure donations to be made via the Mode App as Mode uses Strong Customer Authentication (SCA) measures including biometric security. All customers will be fully authenticated by Mode, reducing the chance of fraud and ensuring that donations are received directly from trusted consumers.

 

Joanna Hancock, Head of Partnerships, Young Lives vs Cancer said: "We're absolutely delighted to be partnering with Mode. Their next-gen financial ecosystem allows customers to support Young Lives vs Cancer, completely fee-free. Young Lives vs Cancer helps children, young people and their families face the fear of cancer. Fear of treatment, of families being torn apart and overwhelming money worries. With supporters like Mode and their customers, we can reach more children, young people and families who need our vital support."

 

Ryan Moore, CEO of Mode, said: "We're excited to tap into a new sector which requires an immediate solution to counter rising fees for both charities and donors. Our platform will enable registered charities in the UK to appeal to tech savvy, high value demographics, incurring only a fraction of the payment fees to do so and allowing them to keep more of their hard-earned donations. We're truly excited about the benefits we have been able to bring to the sector and we hope that today marks the start of more long-term partnerships for Mode in this new sector."

 

 

1 Gofundme charge 2.9% + £0.25p per donation transaction: https://www.gofundme.com/c/pricing#GB

Virginmoneygiving charge a one-off payment from charities when they join, then 2% platform fee and a 2.5% payment processing fee on donations. https://uk.virginmoneygiving.com/giving/about-us/fees/ 

Justgiving charge 1.9% + £0.20p per donation and 5% when processing GiftAid https://www.justgiving.com/info/fees-2019-march

 

 

To make a donation to YLvC via Mode visit: https://charity.modeapp.com/

 

- End -

 

 

About Young Lives vs Cancer:

 

When a child is diagnosed with cancer life becomes full of fear, for them and their family. Fear of treatment, but also of families being torn apart, overwhelming money worries, of having nowhere to turn, no one to talk to. At Young Lives vs Cancer, we help families find the strength to face whatever cancer throws at them. Powered by the kindness of our supporters, we'll face it all together. For more information, visit www.younglivesvscancer.org.uk

 

Today, 12 more children and young people in the UK will hear the devastating news that they have cancer. Treatment normally starts immediately, is often given many miles from home and can last for up to three years. Although survival rates are over 80%, cancer remains the single largest cause of death from disease in children and young people in the UK.

 

For more information, an interview or images, please contact: Young Lives vs Cancer: Fabian Devlin on 07786 338089 or email on fabian.devlin@younglivesvscancer.org.uk

 

 

About Mode: 

 

Mode is an LSE-listed fintech company on a mission to build the world's most disruptive ecosystem where exchanging value and growing wealth is seamless for all. Mode is leveraging the power of Bitcoin and Open Banking to deliver on this mission and offer people a one-stop app for growing wealth and spending smarter, as well as provide businesses with a cheaper, safer and smarter way of accepting payments than card payments and boosting loyalty amongst customers.

 

To learn more visit our website at www.modeapp.com or our investor site at www.modeplc.com

 

 

Contact:

 

Maitland/AMO (PR): Kate Pledger mode@maitland.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAPXPALSFEFA
Date   Source Headline
1st Aug 20222:00 pmRNSPrice Monitoring Extension
28th Jul 20227:30 amRNSResults of Annual General Meeting
18th Jul 20224:36 pmRNSPrice Monitoring Extension
15th Jul 20227:00 amRNSDirectors' Subscription to Loan Notes
13th Jul 20227:00 amRNSCompletion of Fundraising
7th Jul 20227:00 amRNSMode appoints Dr Jose Sanchez Loureda as CTO
29th Jun 20227:00 amRNSNotice of Annual General Meeting
28th Jun 20227:00 amRNSAnnual Report 2021
11th May 20227:00 amRNSMode Announces Changes to Board of Directors
5th May 202211:05 amRNSSecond Price Monitoring Extn
5th May 202211:00 amRNSPrice Monitoring Extension
3rd May 20227:00 amRNSProduct Launch
12th Apr 20221:00 pmRNSBitcoin payroll partnership with Lano
31st Mar 20224:40 pmRNSSecond Price Monitoring Extn
31st Mar 20224:35 pmRNSPrice Monitoring Extension
31st Mar 20222:06 pmRNSSecond Price Monitoring Extn
31st Mar 20222:01 pmRNSPrice Monitoring Extension
31st Mar 202211:06 amRNSSecond Price Monitoring Extn
31st Mar 202211:00 amRNSPrice Monitoring Extension
30th Mar 20224:41 pmRNSSecond Price Monitoring Extn
30th Mar 20224:36 pmRNSPrice Monitoring Extension
24th Mar 202211:06 amRNSSecond Price Monitoring Extn
24th Mar 202211:00 amRNSPrice Monitoring Extension
22nd Mar 20222:05 pmRNSSecond Price Monitoring Extn
22nd Mar 20222:00 pmRNSPrice Monitoring Extension
3rd Mar 20227:00 amRNSAppointment of new CEO
7th Feb 20227:00 amRNSBitcoin payroll partnership with Heroes
19th Jan 202211:06 amRNSSecond Price Monitoring Extn
19th Jan 202211:00 amRNSPrice Monitoring Extension
19th Jan 20229:05 amRNSSecond Price Monitoring Extn
19th Jan 20229:00 amRNSPrice Monitoring Extension
19th Jan 20227:00 amRNSResignation of CEO
1st Dec 20217:00 amRNSAppointment of Independent Non-Executive Director
19th Nov 20219:05 amRNSSecond Price Monitoring Extn
19th Nov 20219:00 amRNSPrice Monitoring Extension
19th Nov 20217:00 amRNSClarification statement
18th Nov 20219:05 amRNSSecond Price Monitoring Extn
18th Nov 20219:00 amRNSPrice Monitoring Extension
18th Nov 20217:00 amRNSMode brings Bitcoin Cashback to 40+ UK retailers
17th Nov 20214:40 pmRNSSecond Price Monitoring Extn
17th Nov 20214:35 pmRNSPrice Monitoring Extension
17th Nov 20217:00 amRNSMode launches 0% fees & partners with A Pompliano
11th Nov 20217:00 amRNSMode partners with PayEscape
9th Nov 20217:00 amRNSMode enters payments partnership with L.K.Bennett
12th Oct 20217:00 amRNSMode payments and Bitcoin rewards live with THG
7th Oct 20217:00 amRNSMode joins leading trade association, CryptoUK
29th Sep 20213:19 pmRNSDirector/PDMR Shareholding
28th Sep 20213:44 pmRNSDirector/PDMR Shareholding
28th Sep 20217:00 amRNSChange of Broker and Financial Adviser
28th Sep 20217:00 amRNSUnaudited Interim Results to 30 June 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.